A carrier-free metal–organic hybrid nanoassembly with combination anti-viral and hepato-protective activity for hepatitis B treatment-Reference-Cited by-同舟云学术

A carrier-free metal–organic hybrid nanoassembly with combination anti-viral and hepato-protective activity for hepatitis B treatment

Published:2022 Issue:15 Volume:10 Page:4356-4366
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Dong He¹,Hong Xiaodan¹,He Yingjiao¹,Bao Zhengxiang¹,Zhang Ying¹,Shen Shiyang¹,Wang Guangji¹,Zhang Jingwei¹,Mo Ran¹^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Metabolism and Pharmacokinetics and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China

Abstract

Co-delivery of an anti-viral agent, tenofovir and an anti-inflammation compound, glycyrrhetinic acid by a carrier-free metal–organic hybrid nanoassembly is reported for combination anti-viral and hepato-protective treatment of hepatitis B.

Funder

China Pharmaceutical University

National Natural Science Foundation of China

Fok Ying Tong Education Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/BM/D2BM00407K

Reference56 articles.

1. Hepatitis B virus infection